MedTrace Logo

Blood Lymphocytes in Asthmatics Treated With Therapeutic Proteins

NCT04514926 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2025-07-30

No results posted yet for this study

Summary

This is an observational, clinic-based, single center study of 120 subjects. Participants will be comprised of patients seen in the outpatient faculty practice in ambulatory care at the UCSF Parnassus campus. Study investigators will enroll 20 healthy participants with no history of lung disease, 50 asthmatics who are newly prescribed therapeutic proteins for their asthma, and 50 asthmatics already being treated with therapeutic proteins for their asthma. Participants will be seen at 1 to 3 visits and provide blood samples at each visit.

Conditions

Sponsors & Collaborators

Principal Investigators

  • John V Fahy, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2023-05-26
Completion
2023-05-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04514926 on ClinicalTrials.gov